These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 18154595)

  • 1. Mucosal innate immunity as a determinant of HIV susceptibility.
    Iqbal SM; Kaul R
    Am J Reprod Immunol; 2008 Jan; 59(1):44-54. PubMed ID: 18154595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial polypeptides are key anti-HIV-1 effector molecules of cervicovaginal host defense.
    Cole AM; Cole AL
    Am J Reprod Immunol; 2008 Jan; 59(1):27-34. PubMed ID: 18154593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of innate immune responses in the female genital tract: friend or foe of HIV-1 infection?
    Firoz Mian M; Ashkar AA
    Am J Reprod Immunol; 2011 Mar; 65(3):344-51. PubMed ID: 21223417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional CD8+ CTLs in mucosal sites and HIV infection: moving forward toward a mucosal AIDS vaccine.
    Belyakov IM; Ahlers JD
    Trends Immunol; 2008 Nov; 29(11):574-85. PubMed ID: 18838298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal immune responses in the genital tract of HIV-1-exposed uninfected women.
    Hirbod T; Broliden K
    J Intern Med; 2007 Jul; 262(1):44-58. PubMed ID: 17598814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genital tract immune milieu: an important determinant of HIV susceptibility and secondary transmission.
    Kaul R; Pettengell C; Sheth PM; Sunderji S; Biringer A; MacDonald K; Walmsley S; Rebbapragada A
    J Reprod Immunol; 2008 Jan; 77(1):32-40. PubMed ID: 17395270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innate immune factors associated with HIV-1 transmission.
    Pollakis G; Stax MJ; Paxton WA
    Curr Opin HIV AIDS; 2011 Sep; 6(5):341-7. PubMed ID: 21825869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to HIV-1 infection: lessons learned from studies of highly exposed persistently seronegative (HEPS) individuals.
    Kulkarni PS; Butera ST; Duerr AC
    AIDS Rev; 2003; 5(2):87-103. PubMed ID: 12876898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal immune dysfunction in AIDS pathogenesis.
    Paiardini M; Frank I; Pandrea I; Apetrei C; Silvestri G
    AIDS Rev; 2008; 10(1):36-46. PubMed ID: 18385779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV infection in the female genital tract: discrete influence of the local mucosal microenvironment.
    Kaushic C; Ferreira VH; Kafka JK; Nazli A
    Am J Reprod Immunol; 2010 Jun; 63(6):566-75. PubMed ID: 20384619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of cytokines and chemokines in the regulation of innate immunity and HIV infection.
    Alfano M; Poli G
    Mol Immunol; 2005 Feb; 42(2):161-82. PubMed ID: 15488606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal vaccines: the promise and the challenge.
    Neutra MR; Kozlowski PA
    Nat Rev Immunol; 2006 Feb; 6(2):148-58. PubMed ID: 16491139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal HIV vaccines: a holy grail or a dud?
    Azizi A; Ghunaim H; Diaz-Mitoma F; Mestecky J
    Vaccine; 2010 May; 28(24):4015-26. PubMed ID: 20412879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV infection and specific mucosal immunity: workshop 4B.
    Challacombe SJ; Fidel PL; Tugizov S; Tao L; Wahl SM
    Adv Dent Res; 2011 Apr; 23(1):142-51. PubMed ID: 21441496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate molecular and anatomic mucosal barriers against HIV infection in the genital tract of HIV‐exposed seronegative individuals.
    Broliden K
    J Infect Dis; 2010 Nov; 202 Suppl 3():S351-5. PubMed ID: 20887223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host factors involved in low susceptibility to HIV infection.
    Restrepo C; Rallón NI; Carrillo J; Soriano V; Blanco J; Benito JM
    AIDS Rev; 2011; 13(1):30-40. PubMed ID: 21412387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV vaccine and genital secretory immune response.
    Stefanache-Guihard AI
    Rom J Virol; 1995; 46(1-2):85-98. PubMed ID: 9106405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral immune responses to the human immunodeficiency virus type-1 (HIV-1) in the genital tract compared to other mucosal sites.
    Mestecky J
    J Reprod Immunol; 2006 Dec; 72(1-2):1-17. PubMed ID: 17095369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal immunization of young mice with a multigene HIV-1 vaccine in combination with the N3 adjuvant induces mucosal and systemic immune responses.
    Bråve A; Hallengärd D; Schröder U; Blomberg P; Wahren B; Hinkula J
    Vaccine; 2008 Sep; 26(40):5075-8. PubMed ID: 18450334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. War and peace between WAP and HIV: role of SLPI, trappin-2, elafin and ps20 in susceptibility to HIV infection.
    Drannik AG; Henrick BM; Rosenthal KL
    Biochem Soc Trans; 2011 Oct; 39(5):1427-32. PubMed ID: 21936827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.